Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Deepspatial Inc. AGM Information 2022

Feb 3, 2022

46995_rns_2022-02-03_76774221-528b-4351-ac65-de8893b4aaeb.pdf

AGM Information

Open in viewer

Opens in your device viewer

DEEPSPATIAL INC.

NOTICE OF MEETING

AND

MANAGEMENT INFORMATION CIRCULAR

FOR THE

ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD AT 10:00 AM ON MARCH 1, 2022

JANUARY 25, 2022

DEEPSPATIAL INC. (formerly, Aylen Capital Inc.) 77 King Street West, Suite 3000, Toronto, Ontario M5K 1G8 Telephone: 647 889-6916 Email: [email protected] www.deepspatial.ai

NOTICE OF ANNUAL GENERAL MEETING

NOTICE IS HEREBY GIVEN THAT the annual general (the " Meeting ") of shareholders (collectively, the " Shareholders ") of DeepSpatial Inc. (the " Corporation ") will be held at 77 King Street West, Suite 3000, Toronto, Ontario M5K 1G8 on Tuesday, March 1, 2022 at 10:00 a.m. (Toronto time), for the following purposes:

  • (1) to receive the audited financial statements of the Corporation for its fiscal years ended June 30, 2021 and June 30, 2020, the accompanying auditor reports thereon, and related management discussion and analysis;

  • (2) to re-elect Rahul Kushwah, Sheldon Kales, Nandan Mishra and Tomas Sipos as directors of the Corporation;

  • (3) to appoint Harbourside CPA, LLP as the auditor of the Corporation for the fiscal year ending June 30, 2022 and to authorize the directors to fix remuneration to be paid to the auditors for the fiscal ending June 30, 2022; and

  • (4) to transact such other business as may properly come before the Meeting or any adjournment thereof.

The specific details of the matters proposed to be put before the Meeting are set forth in the management information circular (the " Circular ") accompanying this notice of Meeting (the " Notice of Meeting "). The Circular provides further information respecting proxies and the matters to be considered at the Meeting and is deemed to form part of this Notice.

As provided in the Canada Business Corporations Act , the directors have fixed a record date of January 21, 2022. Accordingly, persons who are registered as Shareholders on the books of the Corporation at the close of business on January 21, 2022, are entitled to notice and to vote at the Meeting.

A quorum for the Meeting will consist of one or more persons, present in person or represented by proxy, holding in the aggregate not less than 10% of the votes attached to all outstanding common shares of the Corporation entitled to vote at the Meeting. If a quorum is present at the opening of the Meeting, the Shareholders present or represented by proxy may proceed with the business of the Meeting notwithstanding that a quorum is not present throughout the Meeting. If a quorum is not present at the opening of the Meeting, the Meeting may be adjourned.

If you are a non-registered Shareholder of the Corporation and received this Notice of Meeting and accompanying materials through a broker, a financial institution, a participant, or a trustee or administrator of a retirement savings plan, retirement income fund, education savings plan or other similar savings or investment plan registered under the Income Tax Act (Canada), or a nominee of any of the foregoing that holds your securities on your behalf (each, an " Intermediary "), please complete and return the materials in accordance with the instructions provided to you by your Intermediary.

1

IMPORTANT NOTE: In light of the continually evolving news, guidelines and requirements related to COVID-19, the Corporation will be strictly restricting physical access to the meeting to the registered Shareholders and formally appointed proxyholders, and will not be permitting any others (including beneficial holders that hold their shares through an Intermediary) to attend.

We recommend that Shareholders submit a form of proxy or voting instruction form in advance of the Meeting in a timely fashion as described in the accompanying Circular. Due to the restrictions in attendance, we also recommend that Shareholders not appoint a proxyholder to participate in and vote during the Meeting other than the management representatives named in the accompanying Circular, as they would not be able to physically attend the Meeting.

DATED at Toronto, Ontario this 25th day of January, 2022.

BY ORDER OF THE BOARD OF DIRECTORS

/s/ " Rahul Kushwah"

Name: Rahul Kushwah Title: Chief Executive Officer

2

DEEPSPATIAL INC. (formerly, Aylen Capital Inc.) 77 King Street West, Suite 3000, Toronto, Ontario M5K 1G8 Telephone: 647 889-6916 Email: [email protected] www.deepspatial.ai

MANAGEMENT INFORMATION CIRCULAR

As at January 25, 2022 (unless otherwise indicated)

This management information circular (the " Circular ") is furnished in connection with the solicitation of proxies by management of DeepSpatial Inc. (the " Corporation ") for use at the annual general meeting (the " Meeting ") of the holders (collectively, the " Shareholders ") of common shares of the Corporation (each, a " Common Share ") to be held on Tuesday, March 1, 2022, at the time, place and for the purposes set forth in the accompanying notice of Meeting (the " Notice of Meeting ").

COVID-19 Pandemic

In light of ongoing concerns related to the COVID-19 pandemic and the Province of Ontario's emergency measures concerning public gatherings, the Corporation is encouraging Shareholders and guests not to attend the Meeting in person, as physical access is being restricted due to COVID-19 guidelines. Instead, Shareholders are encouraged to vote on the matters before the Meeting by proxy. Should the prevailing advice from provincial authorities require or recommend any additional change(s) to the Meeting, updates will be posted on the Corporation's website or by press release.

Management Solicitation of Proxies

The solicitation of proxies by management of the Corporation will be conducted by mail and may be supplemented by telephone or other personal contact to be made without special compensation to any of the directors, officers and employees of the Corporation. The Corporation does not reimburse Shareholders, nominees or agents for costs incurred in obtaining from their principals authorization to execute forms of proxy, except that the Corporation has requested brokers and nominees who hold Common Shares in their respective names to furnish the proxy materials to their customers who are NOBOs (as defined below), though the Corporation will not reimburse such brokers and nominees for their related out of pocket expenses. No solicitation will be made by specifically engaged employees or soliciting agents. The cost of solicitation will be borne by the Corporation.

No person has been authorized to give any information or to make any representation other than as contained in this Circular in connection with the solicitation of proxies. If given or made, such information or representations must not be relied upon as having been authorized by the Corporation. The delivery of this Circular shall not create, under any circumstances, any implication that there has been no change in the information set forth herein since the date of this Circular. This Circular does not constitute the solicitation of a proxy by anyone in any jurisdiction in which such solicitation is not authorized, or in which the person making such solicitation is not qualified to do so, or to anyone to whom it is unlawful to make such an offer of solicitation.

Appointment of Proxy

The Common Shares represented by the accompanying form of proxy (if the same is properly executed in favour of Rahul Kushwah, Chief Executive Officer (" CEO "), or failing him, Rakesh Malhotra, Chief Financial Officer (" CFO ") and Secretary, together the management nominees, and is deposited with

1

Computershare Trust Company of Canada at 100 University Avenue, Toronto ON M5J 2X1 (the " Transfer Agent ") at least 48 hours (excluding Saturdays, Sundays and holidays) preceding the Meeting or at any adjournment thereof) will be voted at the Meeting, and where a choice is specified in respect of any matter to be acted upon, will be voted in accordance with the specifications made. In the absence of such a specification, such Common Shares will be voted IN FAVOUR of such matter. The form of proxy sets out specific instructions for completing and returning the proxy in order to be properly counted at the Meeting.

The accompanying form of proxy confers discretionary authority upon the persons named therein with respect to amendments or variations to matters identified in the annexed Notice of Meeting, and with respect to other matters which may properly come before the Meeting. At the date hereof, management of the Corporation knows of no such amendments, variations or other matters.

Each Shareholder has the right to appoint a person other than the persons named in the accompanying form of proxy, who need not be a Shareholder, to attend and act for him and on his behalf at the Meeting. Any Shareholder wishing to exercise such right may do so by inserting in the blank space provided in the accompanying form of proxy the name of the person whom such Shareholder wishes to appoint as proxy and by duly depositing such proxy, or by duly completing and depositing another proper form of proxy.

Revocation of a Proxy

A Shareholder who has given a proxy may revoke it, as to any motion on which a vote has not already been cast pursuant to the authority conferred by it, by an instrument in writing executed by the Shareholder or by the Shareholder's attorney authorized in writing or, if the Shareholder is a corporation, under its corporate seal or by an officer or attorney thereof duly authorized. The revocation of a proxy, in order to be acted upon, must be deposited with Computershare Trust Company of Canada at 100 University Avenue, Toronto ON M5J 2X1 prior to 5:00 p.m. on the last business day immediately preceding the Meeting or with the chairman of the Meeting before the commencement of the Meeting or at any adjournment thereof, or thereafter with the chairman of the Meeting on the day of the Meeting or any adjournment thereof, and upon either of such deposits the proxy is revoked. A proxy may also be revoked in any other manner permitted by law.

Registered Shareholders

If you are a registered Shareholder, you may wish to vote by proxy whether or not you attend the Meeting. Registered Shareholders electing to submit a proxy may do so by completing, dating and signing the enclosed form of proxy and returning it to the Transfer Agent, at least 48 hours (excluding Saturdays, Sundays and holidays) preceding the Meeting or at any adjournment thereof

In all cases, to be represented at the Meeting, proxies submitted must be received no later than 48 hours, excluding Saturdays, Sundays and holidays, prior to the time of the Meeting or any adjournment thereof.

Advice to Beneficial Shareholders

The information set out in this section is of significant importance to those Shareholders who do not hold Common Shares in their own name. Shareholders who do not hold their Common Shares in their own name (referred to in this Circular as "Beneficial Shareholders") should note that only proxies deposited by Shareholders whose names appear on the records of the Corporation as the registered holders of Common Shares can be recognized and acted upon at the Meeting. If Common Shares are listed in an account statement provided by a broker, then in almost all cases those Common

2

Shares will not be registered in the Beneficial Shareholder's name on the records of the Corporation. Such Common Shares will more likely be registered under the names of the Beneficial Shareholder's broker or an agent of that broker. In the United States, the vast majority of such Common Shares are registered under the name of Cede & Co. as nominee for The Depository Trust Company (which acts as depositary for many U.S. brokerage firms and custodian banks), and in Canada, under the name of CDS & Co. (the registration name for The Canadian Depository for Securities Limited, which acts as nominee for many Canadian brokerage firms). Beneficial Shareholders should ensure that instructions respecting the voting of their Common Shares are communicated to the appropriate person well in advance of the Meeting.

The Corporation does not have access to the names of all Beneficial Shareholders. Applicable regulatory policy requires intermediaries/brokers to seek voting instructions from Beneficial Shareholders in advance of Shareholders' meetings. Every intermediary/broker has its own mailing procedures and provides its own return instructions to clients, which should be carefully followed by Beneficial Shareholders in order to ensure that their Common Shares are voted at the Meeting. The form of proxy supplied to a Beneficial Shareholder by his, her or its broker (or the agent of the broker) is similar to the form of proxy provided to registered Shareholders by the Corporation. However, its purpose is limited to instructing the registered Shareholder (the broker or agent of the broker) how to vote on behalf of the Beneficial Shareholder. The majority of brokers now delegate responsibility for obtaining instructions from clients to Broadridge Financial Solutions, Inc. (" Broadridge ") in the United States and in Canada. Broadridge typically prepares a special voting instruction form, mails this form to the Beneficial Shareholders and asks for appropriate instructions regarding the voting of Common Shares to be voted at the Meeting. If Beneficial Shareholders receive the voting instruction forms from Broadridge, they are requested to complete and return the voting instruction forms to Broadridge by mail or facsimile. Alternatively, Beneficial Shareholders can call a tollfree number and access Broadridge's dedicated voting website (each as noted on the voting instruction form) to deliver their voting instructions and to vote the Common Shares held by them. Broadridge then tabulates the results of all instructions received and provides appropriate instructions respecting the voting of Common Shares to be represented at the Meeting. A Beneficial Shareholder receiving a Broadridge voting instruction form cannot use that form as a proxy to vote Common Shares directly at the Meeting – the voting instruction form must be returned to Broadridge well in advance of the Meeting in order to have the applicable Common Shares voted at the Meeting.

Although a Beneficial Shareholder may not be recognized directly at the Meeting for the purposes of voting Common Shares registered in the name of his, her or its broker (or agent of the broker), a Beneficial Shareholder may attend at the Meeting as proxyholder for the registered Shareholder and vote the Common Shares in that capacity. Beneficial Shareholders who wish to attend at the Meeting and indirectly vote their Common Shares as proxyholder for the registered Shareholder should enter their own names in the blank space on the instrument of proxy provided to them and return the same to their broker (or the broker's agent) in accordance with the instructions provided by such broker (or agent), well in advance of the Meeting.

Alternatively, a Beneficial Shareholder may request in writing that his, her or its broker send to the Beneficial Shareholder a legal proxy which would enable the Beneficial Shareholder to attend at the Meeting and vote his, her or its Common Shares.

Beneficial Shareholders consist of non-objecting beneficial owners (each, a " NOBO ") and objecting beneficial owners (each, an " OBO "). A NOBO is a beneficial owner of securities that has provided instructions to an intermediary holding the securities in an account on behalf of the beneficial owner that the beneficial owner does not object, for that account, to the intermediary disclosing ownership information about the beneficial owner under National Instrument 54-101 - Communication with Beneficial Owners of Securities of a Reporting Issuer (" NI 54-101 ") of the Canadian Securities Administrators. An OBO means a beneficial owner of securities that has provided instructions to an intermediary holding the securities in

3

an account on behalf of the beneficial owner that the beneficial owner objects, for that account, to the intermediary disclosing ownership information about the beneficial owner under NI 54-101.

The Corporation is not sending proxy-related materials directly to NOBOs of the Common Shares. The Corporation will not pay for the delivery of proxy-related materials to OBOs of the Common Shares.

All references to Shareholders in this Circular are to registered Shareholders, unless specifically stated otherwise.

Notice to Shareholders in the United States

The solicitation of proxies involves securities of an issuer located in Canada and is being effected in accordance with the applicable federal laws of Canada. The proxy solicitation rules of the United States Securities Exchange Act of 1934 , as amended, are not applicable to the Corporation or this solicitation, and this solicitation has been prepared in accordance with the disclosure requirements of Canadian securities laws applicable to the Corporation. Shareholders should be aware that disclosure requirements under the Canadian securities laws applicable to the Corporation differ from the disclosure requirements under United States securities laws.

INTEREST OF CERTAIN PERSONS OR COMPANIES IN MATTERS TO BE ACTED UPON

No director or executive officer of the Corporation, or any person who has held such a position since the beginning of the last completed financial year of the Corporation, nor any nominee for election as a director of the Corporation, nor any associate or affiliate of the foregoing persons, has any substantial or material interest, direct or indirect, by way of beneficial ownership of securities or otherwise, in any matter to be acted on at the Meeting, other than the election of directors.

VOTING SECURITIES AND PRINCIPAL HOLDERS OF VOTING SECURITIES

The board of directors (the " Board ") of the Corporation have fixed January 21, 2022 as the record date (the " Record Date ") for determining persons entitled to receive notice and to vote at the Meeting. Only those Shareholders who are recorded as such record holders as at the close of business on the Record Date may attend the Meeting or complete, sign and deliver a form of proxy in the manner and subject to the provisions described above and have their Common Shares voted at the Meeting.

A quorum for the Meeting will consist of one or more persons, present in person or represented by proxy, holding in the aggregate not less than 10% of the votes attached to all outstanding Common Shares entitled to vote at the Meeting.

The Common Shares are listed for trading on the Canadian Securities Exchange (the " CSE ") and the OTCQB Venture Market (" OTCQB "). As of the Record Date, there were 93,654,509 Common Shares issued and outstanding, each carrying the right to one (1) vote per Common Share.

To the knowledge of the Board and executive officers of the Corporation, no person or corporation beneficially owns, directly or indirectly, or exercises control or direction over, more than 10% of the issued and outstanding Common Shares other than the following: Sheldon Kales, who holds 15,050,000 Common Shares or approximately 16.1% of the issued and outstanding Common Shares; Rahul Kushwan, who holds 12,050,000 Common Shares or approximately 12.9% of the issued and outstanding Common Shares; and Algo8 AI Private Limited (" Algo8 ") (Nandan Mishra owns approximately 39.5% of Algo8) who holds 21,450,000 Common Shares or approximately 22.9% of the issued and outstanding Common Shares.

4

VOTES NECESSARY TO PASS RESOLUTIONS

Unless otherwise stated, a simple majority of affirmative votes cast at the Meeting is required to pass the ordinary resolutions described herein. If there are more nominees for election as directors than there are vacancies to fill, those nominees receiving the greatest number of votes will be elected or appointed, as the case may be, until all such vacancies have been filled. If the number of nominees for election or appointment is equal to the number of vacancies to be filled, all such nominees will be declared elected or appointed by acclamation.

PRESENTATION OF FINANCIAL STATEMENTS

The annual financial statements of the Corporation for the financial years ended June 30, 2021 and June 30, 2020, together with the auditor's report thereon and the related management's discussion and analysis, all of which may be obtained from SEDAR at www.sedar.com, will be presented to Shareholders at the Meeting.

PARTICULARS OF MATTERS TO BE ACTED UPON

A. Number of Directors

The Corporation's articles (the " Articles ") provide that the number of directors of the Corporation will be a minimum of three (3). Pursuant to the Canada Business Corporations Act (the " CBCA ") and the Articles, the Board has determined that there will be four (4) persons elected to the Board at the Meeting. Unless a director's office is earlier vacated in accordance with the provisions of the CBCA, each elected director will hold office until the conclusion of the next annual meeting of the Corporation, or if no director is then elected, until a successor is elected.

B. Election of Directors

The following table sets out the names of management's four (4) nominees for election as directors (all which currently sit as directors on the Board), all major offices and positions with the Corporation and any of its significant affiliates each now holds, each nominee's principal occupation, business or employment, the period of time during which each has been a director of the Corporation and that number of Common Shares beneficially owned by each, directly or indirectly, or over which each exercised control or direction, as at the Record Date.

Name and Residence Principal Occupation and Director Common Shares
of Proposed
Present Offices Held
Since Beneficially Owned,
Directors or Controlled or Directed,
Directly or
Indirectly as at the
Record Date
Rahul Kushwah(1)
Director and CEO
(Ontario, Canada)
Director and CEO of the
Corporation. Director and Chief
Operating Officer ("COO") of
Predictmedix Inc. since September
23, 2019.
Scientist and researcher for
various institutions.
December
22, 2020
12,050,000

5

Sheldon Kales(1)
Chairman
(Ontario, Canada)
Chairman of the Corporation.
Director and CEO of Predictmedix
Inc. since September 23, 2019.
Investor for various endeavours.
December
22, 2020
15,050,000(2)
Tomas Sipos(1)
Director
(Ontario, Canada)
Director of the Corporation. Mr.
Sipos acts as the Chief Financial
Officer ("CFO") of Pistil Partners
Inc. He has also
been a Director of Predictmedix
Inc. since September 23, 2019.
December
22, 2020
150,000
Nandan Mishra
Director and Chief
Technology Officer
("CTO")
(Lucknow, U.P., India)
Director and CTO of the
Corporation. Technology and AI
Specialist.
December
22, 2020
8,472,750(3)

Notes:

(1) Proposed and current members of the Audit Committee of the Board.

(2) 4,050,000 Common Shares are held in his name (Sheldon Kales), 9,500,000 Common Shares are held by a wholly-owned company (Green Acres Medical Corp.), and 1,500,000 Common Shares are held by Sheldon Kale's wife (Tally Bodenstein).

(3) 21,450,000 Common Shares are held by Algo8. Nandan Mishra owns approximately 39.5% of this company.

Cease Trade Orders and Bankruptcies

For purposes of the disclosure in this section, an "order" means a cease trade order, an order similar to a cease trade order, or an order that denied the relevant company access to any exemption under securities legislation, in each case that was in effect for a period of more than 30 consecutive days; and for purposes of item (a)(i) below, specifically includes a management cease trade order which applies to directors or executive officers of a relevant company that was in effect for a period of more than 30 consecutive days whether or not the proposed director was named in the order.

None of the proposed directors, including any personal holding company of a proposed director:

  • (a) is, as at the date of this Circular, or has been, within the 10 years before the date of this Circular, a director, CEO or CFO of any company (including the Corporation) that:

  • (i) was subject to an order that was issued while the proposed director was acting in the capacity as a director, CEO or CFO of the company; or

  • (ii) was subject to an order that was issued after the proposed director ceased to be a director, CEO or CFO and which resulted from an event that occurred while that person was acting in the capacity as a director, CEO or CFO of the company; or

6

  • (b) is, as at the date of this Circular, or has been, within the 10 years before the date of this Circular, a director or executive officer of any company (including the Corporation) that, while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or was subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold its assets;

  • (c) has, within the 10 years before the date of this Circular, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold the assets of the proposed director;

  • (d) has been subject to any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority since December 31, 2000, or before December 31, 2000 if the disclosure of which would likely be important to a reasonable securityholder in deciding whether to vote for a proposed director; or

  • (e) has been subject to any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable securityholder in deciding whether to vote for a proposed director.

C. Appointment of Auditors and Fixing the Remuneration

At the Meeting, Shareholders will be asked to pass an ordinary resolution to re-appoint Harbourside CPA, LLP as auditors of the Corporation for the fiscal year ending June 30, 2022, and to authorize the directors of the Corporation to fix the remuneration to be to be paid to the auditors for the fiscal year ending June 30, 2022.

Shareholders will be asked to approve the resolution appointing the auditors and authorizing the directors to fix their remuneration. To be approved, the resolution must be passed by the majority of the votes cast by the holders of Common Shares at the Meeting. Management recommends a vote FOR the resolution approving the appointment of the auditor and authorizing the directors to fix the auditor's remuneration.

AUDIT COMMITTEE

The Corporation's audit committee (the " Audit Committee ") is responsible for the Corporation's financial reporting process and quality of its financial reporting. The Audit Committee is charged with the mandate of providing independent review and oversight of the Corporation's financial reporting process, the system of internal control and management of financial risks, and the audit process, including the selection, oversight and compensation of the Corporation's external auditors. In performing its duties, the Audit Committee maintains effective working relationships with the Board, management, and the external auditors and monitors the independence of those auditors. The full text of the charter of the Corporation's Audit Committee (the " Audit Committee Charter ") is attached hereto as Schedule "A".

7

Composition of the Audit Committee

The Audit Committee is comprised of the following:

Name Independent(1) Financially Literate(2)
Sheldon Kales Yes Yes
Tomas Sipos Yes Yes
Rahul Kushwah No Yes

Notes:

(1) A member of the Audit Committee is independent if the member has no direct or indirect material relationship with the Corporation, which could, in the view of the Board, reasonably interfere with the exercise of a member's independent judgment.

(2) An individual is financially literate if he has the ability to read and understand a set of financial statements that present a breadth of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Corporation's financial statements.

Relevant Education and Experience

Name of Member Relevant Experience and Qualifications
Sheldon Kales Mr. Kales is a serial entrepreneur and a business leader. He has extensive
leadership experience in managing and operating research and development
operations of technology companies across the United States, Canada and the
Middle East. He has also served as a director and/or officer of several publicly
listed companies.
Tomas Sipos Mr. Sipos has longstanding experience in corporate finance and investment
banking and served as a senior executive of several companies including Vice
President, Mergers and Acquisitions of Ernst &Young (Toronto) and Managing
Director of Investment Banking European Privatization & Investment Corporation
and Senior Investment Banker for the International Finance Corporation. Mr.
Sipos holds a (Honors) Bachelor of Science in chemical engineering from Queen's
University and a MBA from the University of Toronto, Rotman School of
Business.
Rahul Kushwah Mr. Kushwah is an accomplished scientist. He currently also serves as the Chief
Operating Officer of Predictmedix Inc. (CSE:PMED; OTCQB:PMEDF). Prior to
joining the Corporation, Rahul Kushwah held a faculty appointment with the
Faculty of Medicine at the University of Ottawa and was an accomplished federal
government scientist with the Human Health Therapeutics branch of the National
Research Council of Canada. Additionally, he has served as a consulting scientist
with the Hospital for Sick Children in Toronto, Ontario, and is a regular speaker
at several international speaking engagements. Rahul Kushwah has also authored
several publications in medical journals and serves as a reviewer and editor for
several journals in the medical field. Rahul Kushwah received his doctorate from
the University of Toronto and has been a recipient of the Banting Post-Doctoral
Fellowship in Medicine and CIHR Post-Doctoral Fellowship.

8

Audit Committee Oversight

Since the commencement of the Corporation's most recently completed financial year, there has not been a recommendation of the Audit Committee to nominate or compensate an external auditor which was not adopted by the Board.

Pre-Approval Policies and Procedures

In the event that the Corporation wishes to retain the services of the Corporation's external auditors for any non-audit services, prior approval of the Audit Committee must be obtained.

Audit Fees

In the following table, " audit fees " are fees billed by the Corporation's external auditor for services provided in auditing the Corporation's annual financial statements for the subject year. " Audit-related fees " are fees not included in audit fees that are billed by the auditor for assurance and related services that are reasonably related to the performance of the audit review of the Corporation's financial statements. " Tax fees " are fees billed by the auditor for professional services rendered for tax compliance, tax advice and tax planning. " All other fees " are fees billed by the auditor for products and services not included in the foregoing categories.

The aggregate fees billed by the Corporation's external auditor in the last two fiscal years, by category, are as follows:

Year ended June 30, 2021 Year ended June 30, 2020
($)
($)
Audit fees 33,000 30,000
Audit related fees - -
Tax fees - -
All other fees - -

STATEMENT OF EXECUTIVE COMPENSATION

General

For the purpose of this Statement of Executive Compensation:

" compensation securities " includes stock options, convertible securities, exchangeable securities and similar instruments including stock appreciation rights, deferred share units and restricted stock units granted or issued by the Corporation or one of its subsidiaries (if any) for services provided or to be provided, directly or indirectly to the Corporation or any of its subsidiaries (if any);

9

" NEO " or " Named Executive Officer " means:

  • (a) each individual who served as CEO of the Corporation, or who performed functions similar to a CEO, during any part of the most recently completed financial year,

  • (b) each individual who served as CFO of the Corporation, or who performed functions similar to a CFO, during any part of the most recently completed financial year,

  • (c) the most highly compensated executive officer of the Corporation or any of its subsidiaries (if any) other than individuals identified in paragraphs (a) and (b) at the end of the most recently completed financial year whose total compensation was more than $150,000, as determined in accordance with subsection 1.3(5) of Form 51-102F6V, for that financial year, and

  • (d) each individual who would be a NEO under paragraph (c) but for the fact that the individual was neither an executive officer of the Corporation or its subsidiaries (if any), nor acting in a similar capacity, at the end of that financial year;

" plan " includes any plan, contract, authorization or arrangement, whether or not set out in any formal document, where cash, compensation securities or any other property may be received, whether for one or more persons; and

" underlying securities " means any securities issuable on conversion, exchange or exercise of compensation securities.

The Corporation's NEOs for each of the Corporation's two most recently completed financial years were: Rahul Kushwah (current CEO), Rakesh Malhotra (current CFO and Secretary), Nandan Mishra (current CTO), Richard Sutton (former President and CEO), John D. Pennal (former President and CEO), and Alex Falconer (former CFO).

Compensation Discussion and Analysis

This section sets out the objectives of the Corporation's executive compensation arrangements, the Corporation's executive compensation philosophy and the application of this philosophy to the Corporation's executive compensation arrangements. It also provides an analysis of the compensation design, and the decisions that the Board made in fiscal year 2021 with respect to the NEOs. The Corporation considers the following objectives when determining compensation arrangements for the NEOs: (i) retaining an executive critical to the success of the Corporation and the enhancement of shareholder value; (ii) providing fair and competitive compensation; (iii) balancing the interests of management and Shareholders; and (iv) rewarding performance, both on an individual basis and with respect to the business in general.

Benchmarking

A variety of factors are considered when designing and establishing, reviewing and making recommendations for executive compensation arrangements for all executive officers of the Corporation. The Board typically does not position executive pay to reflect a single percentile within the industry for each executive. Rather, in determining the compensation level for each executive, a variety of factors are considered, such as the relative complexity of the executive's role within the organization, the executive's performance and potential for future advancement, the compensation paid by the other companies in comparative industries, and pay equity considerations.

10

Elements of Named Executive Officer Compensation

The compensation paid to the Corporation's NEOs generally consists of two primary components: a base salary; and long-term incentives in the form of stock options (" Options "), restricted share units (" RSUs "), and deferred share units (" DSUs ", and together with Options and RSUs, " Awards ") granted under the Corporation's Omnibus Equity Incentive Plan adopted by the Board on November 1, 2021 (the " Plan "). The key features of these two primary components of compensation are discussed below:

1. Base Salary

Base salary recognizes the value of an individual to the Corporation based on his or her role, skill, performance, contributions, leadership and potential. It is critical in attracting and retaining executive talent in the markets in which the Corporation competes for talent. Base salaries for the NEOs are reviewed annually. Any change in base salary of a NEO is generally determined by an assessment of such executive's performance, a consideration of competitive compensation levels in companies similar to the Corporation and a review of the performance of the Corporation as a whole and the role such executive officer played in such corporate performance.

2. Long-Term Incentives

The Corporation provides long-term incentives to its NEOs in the form of Awards granted pursuant to the Plan as part of its overall executive compensation strategy. The Corporation believes that granting Awards serve the Corporation's executive compensation philosophy in several ways, including: by helping to attract, retain, and motivate talent; aligning the interests of the NEOs with those of Shareholders by linking a specific portion of the officer's total pay opportunity to the share price; and by providing long-term accountability for its NEOs. Please see Stock Option Plans and Other Incentive Plans for a more detailed description of the Plan.

Risks Associated with Compensation Policies and Practices

The Corporation's executive compensation policies and practices are intended to align management incentives with the long-term interests of the Corporation and its Shareholders. In each case, the Corporation seeks an appropriate balance of risk and reward. Practices that are designed to avoid inappropriate or excessive risks include: (i) financial controls that provide limits and authorities in areas such as capital and operating expenditures to mitigate risk taking that could affect compensation, (ii) balancing base salary and variable compensation elements, and (iii) spreading compensation across short and long-term programs.

Director and Named Executive Officer Compensation

The following table sets forth compensation for each NEO and director of the Corporation for the two most recently completed financial years.

11

Table of compensation excluding compensation securities

Table of compensation excluding compensation securities Table of compensation excluding compensation securities Table of compensation excluding compensation securities Table of compensation excluding compensation securities Table of compensation excluding compensation securities Table of compensation excluding compensation securities Table of compensation excluding compensation securities Table of compensation excluding compensation securities
Name and Year Salary, Bonus
Committee

Value of
Value of all Total
position ended consulting ($) or meeting perquisites(2) other compensation
June fees ($) fees ($) ($) compensation
($)
30(1) ($)
Rahul
Kushwah(3)
CEO and
Director
2021
2020
78,000
N/A
-
N/A
-
N/A
-
N/A
5,000
N/A
83,000
N/A
Rakesh
Malhotra(4)
CFO and
Secretary
2021
2020
46,480
N/A
-
N/A
-
N/A
-
N/A
-
N/A
46,480
N/A
Nandan
Mishra(5)
CTO and
Director
2021
2020
2,000
N/A
-
N/A
-
N/A
-
N/A
-
N/A
2,000
N/A
Sheldon Kales(6)
Chairman
2021
2020
60,000
N/A
-
N/A
-
N/A
-
N/A
6,500
N/A
66,500
N/A
Tomas Sipos(7)
Director
2021
2020
-
N/A
-
N/A
-
N/A
-
N/A
-
N/A
-
N/A
John D.
Pennal(8)
Former
President and
CEO
2021(14)
2020(1)
N/A
240,000
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
12,500
N/A
252,500
Alex Falconer(9)
Former CFO
2021(14)
2020(1)
N/A
30,000
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
30,000
Richard
Sutton(10) (14)
2021(14)
2020(1)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

12

Former
President and
CEO
Douglas
Babcook(11)
Former Director
2021(14)
2020(1)
N/A
7,500
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
7,500
William Hale(12)
Former Director
2021(14)
2020(1)
N/A
7,500
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
7,500
John E. Pennal
(13)
Former Director
2021(14)
2020(1)
N/A
7,500
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
Nil.
N/A
7,500

Notes:

(1) The Corporation formerly had a year end of December 31, 2019 prior to a reverse-takeover transaction with Loc8 Corp. The year end June 30, 2020 values for applicable former directors and officers include the compensation only as at December 31, 2019 year end.

(2) "Perquisites" include perquisites provided to a NEO or director that are not generally available to all employees and that, in aggregate, are: (a) $15,000, if the NEO or director's total salary for the financial year is $150,000 or less, (b) 10% of the NEO or director's salary for the financial year if the NEO or director's total salary for the financial year is greater than $150,000 but less than $500,000, or (c) $50,000 if the NEO or director's total salary for the financial year is $500,000 or greater.

(3) Rahul Kushwah has been a CEO and a director of the Corporation since December 22, 2020.

(4) Rakesh Malhotra has been the CFO and Secretary of the Corporation since December 22, 2020.

(5) Nandan Mishra has been the CTO and a director of the Corporation since December 22, 2020.

(6) Sheldon Kales has been the Chairman of the Corporation since December 22, 2020.

(7) Tomas Sipos has been a director of the Corporation since December 22, 2020.

(8) The late John D. Pennal passed away on October 2, 2020, and was replaced by Richard Sutton as President and CEO on the same date, and by John E. Pennal as director on October 28, 2020.

(9) Alex Falconer resigned as CFO on December 22, 2020, and was replaced by Rakesh Maholtra on the same date.

(10) Richard Sutton resigned as President and CEO on December 22, 2020 and was replaced by Rahul Kushwah on the same date.

(11) Douglas Babcook resigned as director on December 22, 2020.

(12) William Hale resigned as director on December 22, 2020.

(13) John E. Pennal resigned as director on December 22, 2020.

(14) Compensation information is not available on the former directors and NEOs of the Corporation prior to the reverse-takeover transaction with Loc8 Corp except as disclosed for year-end December 30, 2019, if applicable.

Stock Options and Other Compensation Securities

The following table discloses all compensation securities granted or issued to each NEO and director of the Corporation in the most recently completed year June 30, 2021, for services provided or to be provided, directly or indirectly, to the Corporation.

13

Compensation Securities

Compensation Securities Compensation Securities Compensation Securities Compensation Securities Compensation Securities Compensation Securities Compensation Securities Compensation Securities
Name and
position
Type
of
compensati
on security
Number
of
compensatio
n securities,
number
of
underlying
securities,
and
percentage
of class
Date of
issue or
grant
Issue,
conversi
on
or
exercise
price ($)
Closing
price
of
security
or
underlyin
g security
on date of
grant ($)
Closing
price
of
security
or
underlyin
g security
at
year
end ($)
Expiry
date
Rahul
Kushwah
CEO and
Director
Sheldon
Kales
Chairman
Rakesh
Malhotra
CFO and
Secretary
Nandan
Mishra
CTO and
Director
Tomas
Sipos
Director
Stock
options
Stock
options
Stock
options
Stock
options
Stock
options
750,000
750,000
400,000
600,000
200,000
6/4/2021
6/4/2021
6/4/2021
6/4/2021
6/4/2021
0.13
0.13
0.13
0.13
0.13
0.13
0.13
0.13
0.13
0.13
0.17
0.17
0.17
0.17
0.17
6/4/2024
6/4/2024
6/4/2024
6/4/2024
6/4/2024

No current director or NEO of the Corporation exercised compensation securities during the most recently completed financial year, June 30, 2021.

Stock Option Plans and Other Incentive Plans

On November 1, 2021, the Board of the Corporation adopted the Plan to replace its former option plan adopted by the Corporation on December 5, 2011, which consisted of a 10% "rolling" option plan the (" Rolling Plan "). The Plan also includes "rolling" Options which provide for the issuance of such number of Options as is equal to up to 10% of the issued and outstanding Common Shares of the Corporation from time to time, and such number of RSUs and DSUs as is equal to up to 10% of the issued and outstanding Common Shares of the Corporation from time to time. The purpose of the Plan is to: (i) increase the interest in the Corporation's welfare by its directors, officers, senior executives, other employees and consultants

14

(" Eligible Participants "); and (ii) to retain and reward certain Eligible Participants, and attract and retain other persons to the Corporation. The Plan is administered by the Board, which has full and final authority with respect to the granting of all Awards thereunder.

Options may be granted under the Plan to such Eligible Participants of the Corporation and its affiliates, if any, as the Board may from time to time designate. The vesting provisions of Options will be determined by the Board, but will not vest before the first anniversary from the date granted, unless otherwise determined. The exercise price of Options will be determined by the Board, but such price will not be less than the market value of such Common Shares at the time of the grant. All Options granted under the Plan may be exercisable for a period of up to ten (10) years.

DSUs may be awarded to eligible directors by the Board and may form all or a portion of a director's annual retainer fee, to be received in the form of Common Shares or cash equivalents, or a combination of both. DSUs may be redeemed after the director's termination date for a period of up to two years or less, as determined, by providing a DSU Redemption Notice (as defined in the Plan) to the Corporation. If a DSU Redemption Notice is not received by the Corporation on or before the 90th day following the termination date, the director shall be deemed to have delivered a DSU Redemption Notice and the Corporation shall redeem all of the eligible director's DSUs in exchange for Common Shares or cash equivalent.

RSUs may be awarded to a recipient by the Board, subject to meeting certain performance criteria to acquire Common Shares at a price determined by the Board in the form of Common Shares or cash equivalents, or a combination of both. The Board shall determine the vesting terms, but the vesting of RSUs shall not commence before the first anniversary from the date granted, unless otherwise determined. The applicable restriction period for an RSU shall be determined by the Board, except for Eligible Participants subject to the Income Tax Act (Canada), the restricted period shall end no later than December 31 of the calendar year which is three years after the calendar year in which the RSU is granted. The number of vesting RSUs shall be determined by whether certain performance criteria or other conditions are met by the recipient.

Awards may terminate as follows: (i) immediately in the event of dismissal with cause; (ii) 30 days from date of termination other than for cause; (iii) after 90 days from the date of disability; or (iv) 90 days from the date of death. Awards granted under the Plan are not transferable or assignable and may only be exercised by the participant to whom the Award was granted, or upon death or incapacity by a legal representative, or with the Corporation's prior written approval and subject to conditions set by the Corporation.

The above description is qualified entirely by and subject to the terms and conditions of the Plan. Upon request, the Corporation will promptly provide a copy of the Plan free of charge to a Shareholder. A Shareholder may contact the Corporation at its head office at 3000 - 77 King Street West, Toronto, ON M5K 1G8, to request a copy.

Employment, Consulting and Management Agreements

Management functions of the Corporation are substantially performed by directors and senior officers of the Corporation.

CORPORATE GOVERNANCE

Board of Directors

The Board currently consists of four (4) directors. The Board has concluded that Tomas Sipos and Sheldon Kales are "independent" for purposes of Board membership, as defined in National Instrument 58-101 -

15

Disclosure of Corporate Governance Practices . By virtue of their current positions as CEO and CTO, Rahul Kushwah and Nandan Mishra are not considered to be "independent". A member of the Board is considered to be independent if the member has no direct or indirect material relationship with the issuer. A material relationship means a relationship which could, in the view of the reporting issuer's Board, reasonably interfere with the exercise of a member's independent judgment.

Directorships

The following table provides a list of the Corporation's NEOs and directors who have held officer or director positions with reporting issuers over the past five (5) years:

Name Name of Reporting
Issuer
Name of
Exchange or
Market
Position Term
Rahul Kushwah
Sheldon Kales
Tomas Sipos
Rakesh Malhotra
DeepSpatial Inc. CSE; OTCQB Director
CEO
December 2020 to
present
December 2020 to
present
Predictmedix Inc.
DeepSpatial Inc.
CSE; OTCQB
CSE; OTCQB
Director
COO
Director
Chairman
December 2018 to
present
September 2019 to
present
December 2020 to
present
December 2020 to
present
Predictmedix Inc. CSE; OTCQB Director, President
and CEO
September 2019 to
present
Hopewell
Capital
Corporation
DeepSpatial Inc.
TSXV
CSE; OTCQB
Director
Director
January 2017 to
present
December 2020 to
present
Predictmedix Inc.
DeepSpatial Inc.
CSE; OTCQB
CSE; OTCQB
Director
CFO
Secretary
September 2019 to
present
December 2020 to
present
December 2020 to
present

16

Nandan Mishra Nerds on Site Inc. CSE; OTCQB CFO December 2017 to
present
Aion
Therapeutic
Inc.
CSE CFO December 2018 to
present
Predictmedix Inc. CSE; OTCQB CFO September 2019 to
present
Security
Devices
International, Inc.
CSE; OTCQB CFO January 2007 to
November 2019
Binovi Technologies
Inc.
DeepSpatial Inc.
TSX-V;
OTCQB
CSE; OTCQB
CFO
Director
CTO
January 2019 to
present
December 2020 to
present
December 2020 to
present

Board Mandate

The Board has adopted a detailed Board Mandate and Governance Guidelines policy which provides that the Board is responsible for the stewardship of the Corporation and management is responsible for the day-to-day operation of the Corporation. Under the Governance Policy, the Board's mandate is to enhance long-term value for shareholders of the Corporation.

Position Description

Because the Board is a small, working board, it has not developed written position descriptions and does not have a process for assessing the performance of the directors nor the chair of the Board committees.

The CEO of the Corporation is responsible for the general management of the day-to-day affairs of the Corporation within the guidelines established by the Board, consistent with decisions requiring prior approval of the Board and the Board's expectations of the CEO.

Orientation and Continuing Education

All of the current directors are intimately familiar with the Corporation's activities. New directors will be oriented on an informal basis.

Ethical Business Conduct

The Board has adopted a written Code of Ethical Conduct and Business Practices (the " Code ") to ensure that the Corporation's directors, officers and employees act in accordance with applicable laws and observe the highest ethical standards in their business relationships. The Code imposes on every director, officer and employee of the Corporation the responsibility to create and maintain a fair, honest and

17

professional workplace. Given the relatively small size of the Corporation, the Board as a whole is responsible for monitoring and ensuring compliance with the Code. However, the independent directors of the Corporation are encouraged to take a leading role in this process.

Nomination of Directors

The Board does not have a nominating committee given the size of the Corporation. Instead, the Board works together as a whole to identify new candidates for nomination.

Assessments

The Board does not regularly make formal assessments of the Board, its committees and its individual directors, owing to the size and composition of the Board. As a small working board, the Board as a whole satisfies itself on an informal basis, from time-to-time, that the Board, its committees, and its individual directors are performing effectively.

Composition of the Compensation Committee

Owing to the size of the Board and the number of executive officers, the Board does not have a Compensation Committee. The independent directors on the Board deal with compensation issues as and when required.

Corporate Governance Committee

The Board does not have a Corporate Governance Committee, owing to the size and composition of the Board. The Board as a whole is responsible for matters of corporate governance and for the disclosure of the Corporation's corporate governance practices in accordance with NI 58-101 and other legal and regulatory requirements.

Board of Advisors

The Corporation introduced a new board of advisors on March 8, 2021, consisting of technology and business development experts to strategize technology development and to further business development. The board of advisors currently consists of the following members:

  • Sourav Sachin

  • Kapil Raval

  • Andrew Mandyam

  • Roberto Luciano

  • Pulkit Trivedi

Pension Plan Benefits

The Corporation does not have a pension plan.

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

The following table sets out, as at fiscal year ended June 30, 2021, information with respect to the Corporation's compensation plans under which equity securities are authorized for issuance:

18

Plan Category Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
Weighted-average
exercise price of
outstanding options,
warrants and rights
Number of securities
remaining available
for future issuance
under equity
compensation plans
(excluding securities
reflected in column
(a))
(a) (b) (c)
Equity compensation
plans approved by
security holders
9,400,000 0.13 -
Equity compensation
plans not approved by
security holders(1)
- - -
Total 9,400,000 0.13 -

Notes:

(1) The Board recently adopted the Plan on November 1, 2021, which replaces its Rolling Plan, as described above in Stock Option Plans and Other Incentive Plans.

INDEBTEDNESS OF DIRECTORS AND EXECUTIVE OFFICERS

None of the Corporation's directors, executive officers or employees, or former directors, executive officers or employees, nor any associate of such individuals, is as at the date hereof, indebted to the Corporation or any of its subsidiaries in connection with a purchase of securities or otherwise.

INTEREST OF INFORMED PERSONS IN MATERIAL TRANSACTIONS

Except as disclosed in the Corporation's management information circular concerning, among other things, a reverse takeover involving Loc8 Corp. dated November 13, 2020 and available on SEDAR at www.sedar.com, none of the persons who were directors or executive officers of the Corporation or a subsidiary of the Corporation at any time since the commencement of the Corporation's most recently completed fiscal year, the proposed nominees for election to the board of directors of the Corporation, any person or Corporation who beneficially owns, directly or indirectly, or who exercises control or direction over (or a combination of both) more than 10% of the issued and outstanding Common Shares, nor any associate or affiliate of any such person, has any material interest, direct or indirect, by way of beneficial ownership of securities or otherwise, in any transaction, or has any such interest in any proposed transaction, which has materially affected or would materially affect the Corporation.

AUDITORS AND TRANSFER AGENTS

The auditor of the Corporation is Harbourside CPA LLP, which was appointed by the Corporation on September 15, 2021. Its offices are located at 1185 W Georgia St #1140, Vancouver, British Columbia V6E 4E6. Harbourside CPA LLP are independent within the meaning of the Rules of Professional Conduct of the Institute of Chartered Accountants of Ontario.

19

Computershare Trust Company of Canada, through its principal office in Toronto, Ontario, is the transfer agent and registrar of the Corporation.

ADDITIONAL INFORMATION

Financial information is provided in the Corporation's comparative annual financial statements and management's discussion and analysis. Additional information relating to the Corporation is available on SEDAR at www.sedar.com.

OTHER MATTERS

As of the date of this Circular, the Board and management of the Corporation are not aware of any matters to come before the Meeting other than those matters specifically identified in the accompanying Notice of Meeting. However, if such other matters properly come before the Meeting or any adjournment(s) thereof, the persons designated in the accompanying form of proxy will vote thereon in accordance with their judgment, pursuant to the discretionary authority conferred by the form of proxy with respect to such matters.

BOARD APPROVAL

The contents of this Circular and its distribution to Shareholders have been approved by the Board.

DATED this 25th day of January, 2022.

BY ORDER OF THE BOARD OF DIRECTORS

/s/ " Rahul Kushwah"

Name: Rahul Kushwah Title: Chief Executive Officer

20

SCHEDULE "A"

DEEPSPATIAL INC. AUDIT COMMITTEE CHARTER

1. Role of the Committee

The board of directors of DeepSpatial Inc. (the "Corporation") shall appoint an Audit Committee (the "Committee").

The role of the Committee shall be to assist the board to promote and improve the credibility and objectivity of financial reports.

The Committee shall oversee the accounting and financial reporting processes of the Corporation and review and recommend for approval by the board the financial statements, MD&A and earnings news releases.

The Committee will manage the relationship between the Corporation and the external auditors by overseeing the work of the external auditors and by making recommendations to the board on the engagement, remuneration and termination of the external auditors based on its evaluation of performance.

The Committee shall pre-approve all non-audit services the external auditors propose to provide to the Corporation.

The Committee shall facilitate and maintain open communications among management, the external auditors, and the board.

The Committee shall be responsible for the discharge of such other duties as may be prescribed by regulatory authorities or delegated by the board.

2. Membership

The Committee shall be comprised of at least three members, a majority of whom shall be independent as determined by the board in conformity with the laws, regulations and listing requirements to which the Corporation is subject. An independent Committee member is one who has no direct or indirect material relationship with the Corporation. A material relationship means a relationship which could, as determined by the board, reasonably interfere with the exercise of a member's independent judgement.

The Chair of the Committee shall be appointed by the board of directors. A quorum shall consist of two directors.

All members of the Committee shall in the judgment of the board of directors be "financially literate" and if possible, at least one member shall qualify as a "financial expert". "Financially literate" shall mean the ability to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Corporation's financial statements. A "financial expert" shall mean a person who has: (a) an understanding of financial statements and the accounting principles used by the Corporation to prepare its financial statements; (b) the ability to assess the general application of such accounting principles in connection with the accounting for estimates, accruals and reserves; (c) experience preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Corporation's financial statements, or experience actively supervising one or more persons engaged in such activities; (d) an understanding of internal controls and procedures for financial reporting; and (e) an

understanding of audit Committee functions. The designation of a person as a financial expert will not impose any duties, obligations or liabilities greater than those arising by virtue of this person's position as a member of the audit Committee or board of directors.

3. Meetings

The Committee shall meet at least four times per year and at such other times as any member of the Committee deems necessary to fulfill its responsibilities. The Corporation's external auditors will normally not be required to attend meetings of the Committee except for the meeting at which the audited annual financial statements are considered. At each meeting, the Committee shall meet separately with management and the external auditors, if they are present, to discuss any matters the Committee or any of these parties believe should be discussed privately.

4. Reporting to the Board

Minutes of all meetings of the Committee are to be sent to all board members. All supporting schedules and data received and reviewed by the Committee are to be available for examination by any director upon request to the Chairman of the Committee.

5. Authority

The Committee shall have direct access to all books, records, facilities and personnel of the Corporation including to the external auditor as it determines this to be advisable. All employees are to cooperate as requested by Committee members.

The Committee shall have the authority to retain persons having special expertise in legal, accounting or other matters as it determines to be necessary to assist it in discharging its responsibilities. The Committee shall have the authority to set and pay the compensation of any advisors it engages.

The board of directors may authorize the Committee to investigate any activity of the Corporation.

6. Responsibilities

In the discharge of its role, the Committee will have the responsibility to:

  • (a) recommend to the board the external auditors to be nominated for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for the Corporation and the compensation of the external auditors;

  • (b) confirm the external auditors are participants in good standing with the Canadian Public Accountability Board;

  • (c) review the external auditor engagement letter and confirm the direct reporting and accountability of the auditors to the audit Committee and through the Committee to the board of directors as representatives of the shareholders;

  • (d) pre-approve any non-audit services to be provided by the external auditors and generally assess the independence of the external auditors having reference to the Independence Standards of the CICA; the pre-approval requirement may be satisfied if (a) the aggregate amount of all the non-audit services that were not pre-approved constitutes no more that 5% of the total amount of revenues paid by the Corporation to its external auditors during the fiscal year in which the services were provided; (b) the services were not recognized by the Corporation at the time of the engagement to be nonaudit services; and (c) the services were promptly brought to the attention of the Committee and approved, prior to the completion of the audit, by the audit Committee or

by one or more members of the Committee to whom the Committee may delegate authority to grant such approvals;

  • (e) ensure the rotation of the lead audit partner and/or the audit partner responsible for reviewing the audit as required by law;

  • (f) review and approve the Corporation's hiring policies regarding employees or persons previously employed by the present or former external auditors;

  • (g) review the scope of the external auditors' audit plan and the procedures to be utilized with the external auditors and with management.

  • (h) review with management and with the external auditors all major accounting policies and practices adopted, any proposed changes in major accounting policies, the presentation and impact of significant risks and uncertainties, and key estimates and judgments of management that may be material to financial reporting;

  • (i) question management regarding significant variances between comparative reporting periods;

  • (j) review (i) the audited annual financial statements with management and the external auditors and (ii) the quarterly financial statements of the Corporation with management, and recommend the same to the board;

  • (k) question management and the external auditors regarding significant financial reporting issues discussed during the fiscal period and the method of resolution;

  • (l) review any restrictions imposed by management in performing the external audit or significant accounting issues on which there was a disagreement with management;

  • (m) review the post-audit or management letter, containing the recommendations of the external auditors, and management's response and subsequent follow up to any identified weakness;

  • (n) review and recommend for the approval by the board the Management's Discussion & Analysis reports, news releases and any earnings guidance and all public disclosure documents containing audited or unaudited financial information before release;

  • (o) review the quarterly reports issued by management and subsequent follow up to any identified weakness;

  • (p) review with management significant financial risk exposures, the steps taken to monitor and control such exposures and approve any related policies;

  • (q) review the appointments of any key financial executives involved in the financial reporting process;

  • (r) review with management the status of any material pending or threatened litigation;

  • (s) review the adequacy and quality of any insurance coverage maintained by the Corporation;

  • (t) inquire of the CEO as to the Corporation's disclosure controls and procedures and as to the existence of any significant deficiencies in the design or operation of internal controls

and any fraud that involves employees who have a significant role in the Corporation's internal controls; and

  • (u) review the status of compliance with laws and regulations and the scope and status of systems designed to ensure compliance therewith and receive reports from management, legal counsel and other third parties as determined by the Committee on such matters, as well as major legislative and regulatory developments which could impact the Corporation's contingent liabilities and risks.

7. Business Conduct Policies

The Committee will review and reassess annually the adequacy of the Corporation's Code of Ethical Conduct and Business Practices and its policies and procedures with respect to Corporate Disclosure, Confidentiality and Restricted Trading Policies.

8. Allocation of Responsibilities

Management is responsible for operating the business of the Corporation and for its internal controls and the financial reporting process. The external auditors are responsible for performing an independent audit of the Corporation's consolidated financial statements in accordance with generally accepted auditing standards and for issuing a report thereon. The external auditors shall report and be accountable to the Committee and through the Committee to the board of directors as representatives of shareholders. The Committee's responsibility is to monitor and oversee these processes on behalf of the board. The Committee is not charged with the duty to plan or conduct audits or to determine that the Corporation's financial statements are complete and accurate and in accordance with generally accepted accounting principles.

The existence of the Committee and the delegation to it of certain powers and duties by the board of directors does not relieve individual members of the board of directors from the responsibility of satisfying themselves that the affairs of the Corporation are being properly conducted.

9. Complaints

Concerns or complaints submitted to management pursuant to procedures set forth in the Code of Ethical Conduct and Business Practices or otherwise received by an employee of the Corporation, including but not restricted to concerns and complaints which relate to accounting, internal accounting controls or audit matters, shall be referred to the Chair of the Committee. The Committee shall deal with all such internal complaints relating to such matters.

No reprisal, retaliation or disciplinary action shall be taken against employees for reporting, in good faith, such concerns. The Chair of the Committee shall, if requested by the complainant, keep the identity of the complainant in confidence to the extent appropriate or permitted by law.

10. Annual Review

The Committee shall review the adequacy of this Charter on an annual basis and recommend any changes to the board.